Clinical trial
Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder…
NCT00330499 · Trans Tasman Radiation Oncology Group, Other · Completed
Key facts
| NCT number | NCT00330499 |
|---|---|
| Title | Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer. |
| Official title | A Randomised Trial of Radical Chemo/Radiotherapy vs Radiotherapy Alone in the Definitive Management of Localised Muscle Invasive TCC of the Urinary Bladder |
| Lead sponsor | Trans Tasman Radiation Oncology Group, Other |
| Collaborators | National Health and Medical Research Council, Australia |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Transitional Cell Carcinoma of Urinary Bladder |
| Intervention type | Drug, Radiation |
| Interventions | Cisplatin, External beam radiation treatment |
| Enrollment | 67 |
| Start date | Oct 1, 2002 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | May 26, 2006 |
| Last update posted | Jul 12, 2017 |
| Countries | Australia, New Zealand |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: